^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ThisCART7

    i
    Other names: This-CART7, ThisCART7, Allogeneic CAR-T targeting CD7, ThisCART7 cells, This CART7
    Associations

    News

    Trials
    Company:
    Fundamenta Therap
    Drug class:
    CD7-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    3years
    Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies (clinicaltrials.gov)
    P1, N=30, Recruiting, Fundamenta Therapeutics, Ltd.
    Clinical • New P1 trial
    |
    CD7 (CD7 Molecule)
    |
    ThisCART7